Found: 29
Select item for more details and to access through your institution.
COULD THE PARAGRAPH 6 COMPULSORY LICENSE SYSTEM BE REVISED TO INCREASE PARTICIPATION BY THE GENERICS INDUSTRY? LESSONS LEARNED FROM AN UNHERALDED AND UNSUCCESSFUL ATTEMPT TO USE CANADA'S ACCESS TO MEDICINES REGIME.
- Published in:
- McGill Journal of Law & Health / Revue de Droit et Santé de McGill, 2019, v. 12, n. 2, p. 227
- By:
- Publication type:
- Article
The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 1, p. 47, doi. 10.1007/s40258-018-0420-8
- By:
- Publication type:
- Article
In which developing countries are patents on essential medicines being filed?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 9, p. 1319, doi. 10.1038/s41587-022-01451-7
- By:
- Publication type:
- Article
The characteristics of patents impacting availability of biosimilars.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 1, p. 22, doi. 10.1038/s41587-021-01170-5
- By:
- Publication type:
- Article
Identifying potential prescription drug product hopping.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 4, p. 414, doi. 10.1038/s41587-021-00877-9
- By:
- Publication type:
- Article
Pre-market development times for biologic versus small-molecule drugs.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Tertiary patenting on drug-device combination products in the United States.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 2, p. 142, doi. 10.1038/nbt.4078
- By:
- Publication type:
- Article
Will inter partes review speed US generic drug entry?
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 12, p. 1139, doi. 10.1038/nbt.4036
- By:
- Publication type:
- Article
Which patent and where? Why international patent transparency by companies is needed for medicines.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 9, p. 923, doi. 10.1038/nbt.3664
- By:
- Publication type:
- Article
The time for pharmaceutical compulsory licensing has expired.
- Published in:
- Nature Medicine, 2012, v. 18, n. 8, p. 1168, doi. 10.1038/nm0812-1168
- By:
- Publication type:
- Article
COVID-19 and the prevalence of drug shortages in Canada: a cross-sectional time-series analysis from April 2017 to April 2022.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2022, v. 23, n. 194, p. E801, doi. 10.1503/cmaj.212070
- By:
- Publication type:
- Article
Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019.
- Published in:
- PLoS Medicine, 2023, v. 20, n. 11, p. 1, doi. 10.1371/journal.pmed.1004309
- By:
- Publication type:
- Article
Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 7, p. 650, doi. 10.1001/jama.2023.13872
- By:
- Publication type:
- Article
The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258013
- By:
- Publication type:
- Article
Patent "Evergreening" of Medicine--Device Combination Products: A Global Perspective.
- Published in:
- Healthcare Policy, 2022, v. 18, n. 2, p. 14, doi. 10.12927/hcpol.2022.26973
- By:
- Publication type:
- Article
Commentary: Expedited Regulatory Review of Low-Value Drugs.
- Published in:
- Healthcare Policy, 2020, v. 15, n. 4, p. 35
- By:
- Publication type:
- Article
Generic Competition for Drugs Treating Rare Diseases.
- Published in:
- Journal of Law, Medicine & Ethics, 2020, v. 48, n. 4, p. 789, doi. 10.1177/1073110520979391
- By:
- Publication type:
- Article
Approximating Future Generic Entry for New Drugs.
- Published in:
- Journal of Law, Medicine & Ethics, 2019, v. 47, n. 1, p. 177, doi. 10.1177/1073110519840499
- By:
- Publication type:
- Article
Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 2, p. 347, doi. 10.1093/cid/ciab389
- By:
- Publication type:
- Article
Comparing Onset of Biosimilar Versus Generic Competition in the United States.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 6, p. 1308, doi. 10.1002/cpt.1981
- By:
- Publication type:
- Article
Laboratory testing and antihypertensive medication adherence following initial treatment of incident, uncomplicated hypertension: A real‐world data analysis.
- Published in:
- Journal of Clinical Hypertension, 2022, v. 24, n. 10, p. 1316, doi. 10.1111/jch.14567
- By:
- Publication type:
- Article
Effectiveness of individual-focused interventions to prevent chronic disease.
- Published in:
- European Journal of Clinical Investigation, 2014, v. 44, n. 9, p. 883, doi. 10.1111/eci.12298
- By:
- Publication type:
- Article
Modes of delivery in preventive intervention studies: a rapid review.
- Published in:
- European Journal of Clinical Investigation, 2014, v. 44, n. 7, p. 688, doi. 10.1111/eci.12279
- By:
- Publication type:
- Article
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148939
- By:
- Publication type:
- Article
Could patents interfere with the development of a cardiovascular polypill?
- Published in:
- 2016
- By:
- Publication type:
- journal article
The timing of 30‐month stay expirations and generic entry: A cohort study of first generics, 2013–2020.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 5, p. 1917, doi. 10.1111/cts.13046
- By:
- Publication type:
- Article
Identifying subgroups of adult high-cost health care users: a retrospective analysis.
- Published in:
- CMAJ Open, 2022, v. 10, n. 2, p. E390, doi. 10.9778/cmajo.20210265
- By:
- Publication type:
- Article
Solutions for patients visiting the emergency department with non-emergent issues: results from a deliberative public policy analysis process.
- Published in:
- 2024
- By:
- Publication type:
- Letter